← FDA DRUG APPROVALS

FDA ANDA · ANDA074357

TRAZODONE HYDROCHLORIDE

Sponsor: TEVA

APPLICATION
ANDA074357
TYPE
ANDA
ORIGINAL APPROVAL
1997-04-30
LATEST ACTION
2014-11-17
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

TRAZODONE HYDROCHLORIDEDiscontinued
TRAZODONE HYDROCHLORIDE 150MG · TABLET · ORAL

Approval history

2014-11-17Labeling · Supplement 6 · standardAP
2007-06-26Labeling · Supplement 5AP
2001-01-04Labeling · Supplement 4AP
1999-12-02Manufacturing (CMC) · Supplement 2AP
1999-12-02Labeling · Supplement 3AP
1999-12-02Manufacturing (CMC) · Supplement 1AP
1997-04-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →